PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM TREATS FIRST SUBJECTS IN PHASE 3 TRIAL OF ZILOSUL, page-8

  1. 995 Posts.
    lightbulb Created with Sketch. 327
    Boxes keep getting ticked. Hopefully in CY23 we hear back some good news!
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.